Latest Period
Q1 2026
Security Snapshot
NextCure, Inc. - Common Stock, $0.001 par value (NXTC) Institutional Ownership
CUSIP: 65343E207
13F Institutional Holders and Ownership History from Q3 2025 to Q1 2026
Institutions Reporting
26
Shares (Excl. Options)
2,169,454
Price
$10.68
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value
- Symbol
- NXTC on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 2,169,454
- Total 13F value
- $22,952,232
- Portfolio coverage rank
- 0%
- Share change
- +187,315
- Value change
- +$1,884,758
- Number of holders
- 26
- Shares outstanding
- 3,135,972
- SEC-reported price per share
- $10.18
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- NXTC - NextCure, Inc. - Common Stock, $0.001 par value is tracked under CUSIP 65343E207.
- 26 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 24 to 26 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $26,925,657 to $22,952,232.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 26 institutions filings for Q1 2026.
Security key
65343E207
Latest holder period
Q1 2026
13F holders
26
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
NXTC full holder history
NextCure, Inc. SEC filings
NextCure, Inc. company facts
NextCure, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 65343E207:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
NXTC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | 10% | $4,715,825 | 363,035 | Ikarian Capital, LLC | 31 Dec 2025 | |||
| Affinity Asset Advisors, LLC | 10% | +40% | $4,375,018 | +$1,966,899 | 348,607 | +82% | Affinity Asset Advisors, LLC | 22 Jan 2026 |
| Simcere Zaiming, Inc. | 13% | $1,696,566 | 338,636 | Simcere Zaiming, Inc. | 20 Jun 2025 | |||
| Squadron Capital Management LLC | 9.9% | +49% | $3,521,940 | +$1,263,485 | 271,127 | +56% | Squadron Master Fund LP | 31 Dec 2025 |
| Sofinnova Venture Partners IX, L.P. | 7.1% | $2,947,939 | 222,654 | Sofinnova Venture Partners IX, L.P. ("SVP IX") | 19 Dec 2025 | |||
| SILVERARC CAPITAL MANAGEMENT, LLC | 5% | $2,286,980 | 176,057 | SilverArc Capital Management, LLC | 31 Dec 2025 |
As of 31 Mar 2026, 26 institutional investors reported holding 2,169,454 shares of NextCure, Inc. - Common Stock, $0.001 par value (NXTC). This represents 69% of the company’s total 3,135,972 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
69%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Squadron Capital Management LLC | 8.5% | 265,000 | +12% | 1.1% | $2,830,200 |
| Affinity Asset Advisors, LLC | 7.7% | 241,826 | -2.2% | 0.15% | $2,582,702 |
| Ikarian Capital, LLC | 7.6% | 238,303 | 0% | 0.36% | $2,506,947 |
| Sofinnova Investments, Inc. | 7.1% | 222,654 | 0% | 0.12% | $2,377,945 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 5.6% | 176,057 | 0% | 0.22% | $1,880,289 |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.1% | 160,473 | 0% | 0% | $1,688,176 |
| Pfizer Inc | 4.9% | 153,354 | -2.7% | 0.64% | $1,535,074 |
| Opaleye Management Inc. | 4.5% | 141,181 | 0.21% | $1,507,813 | |
| AWM Investment Company, Inc. | 3.7% | 117,371 | 0% | 0.14% | $1,234,743 |
| Exome Asset Management LLC | 3.7% | 115,500 | -30% | 0.71% | $1,215,060 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.2% | 69,617 | 0% | 0.02% | $743,510 |
| RENAISSANCE TECHNOLOGIES LLC | 1.9% | 60,534 | +80% | 0% | $646,503 |
| Verdad Advisers, LP | 1.4% | 42,955 | 0.52% | $458,759 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.99% | 31,092 | +34% | 0% | $327,136 |
| BlackRock, Inc. | 0.89% | 27,793 | 0% | 0% | $296,830 |
| Woodline Partners LP | 0.88% | 27,498 | 0% | $293,679 | |
| CARDIFF PARK ADVISORS, LLC | 0.7% | 21,833 | 0% | 0.02% | $233,176 |
| ACADIAN ASSET MANAGEMENT LLC | 0.61% | 18,982 | -29% | 0% | $199,000 |
| VANGUARD FIDUCIARY TRUST CO | 0.51% | 16,015 | 0% | 0% | $168,478 |
| CITADEL ADVISORS LLC | 0.49% | 15,292 | 0% | $160,872 | |
| BARCLAYS PLC | 0.18% | 5,626 | 0% | 0% | $60,085 |
| UBS Group AG | 0.01% | 338 | 0% | 0% | $3,610 |
| MORGAN STANLEY | 0% | 66 | 0% | 0% | $705 |
| JPMORGAN CHASE & CO | 0% | 61 | 0% | 0% | $587 |
| BNP PARIBAS FINANCIAL MARKETS | 0% | 32 | 0% | 0% | $342 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q1 2026
Rows shown
1-3 of 3